Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-22Sep-30-21Sep-30-20Sep-30-19Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K/A10-K10-K10-K10-K10-K
Revenues   [+]0.20.21.90.00.00.00.00.0
            Revenue growth  -3.9%-90.9%    -100.0%-38.1%
Cost of goods sold  0.20.30.00.00.00.00.00.0
Gross profit  -0.1-0.11.90.00.00.00.00.0
            Gross margin  -41.4%-54.9%98.9%    -4646.1%
Selling, general and administrative   [+]12.46.34.84.32.3   
Research and development  4.93.92.11.50.7   
Other operating expenses  -7.3-0.1      
EBITDA   [+]-9.9-10.1-4.9     
            EBITDA margin  -5790.9%-5690.5%-249.3%    -4646.1%
Depreciation  0.10.10.00.0    
EBITA  -10.0-10.2-4.9-5.8-3.10.00.00.0
            EBITA margin  -5847.1%-5723.3%-250.6%    -4646.1%
Amortization of intangibles  0.00.00.00.00.0   
EBIT   [+]-10.0-10.2-4.9-5.8-3.10.00.00.0
            EBIT margin  -5860.2%-5735.9%-251.7%    -4646.1%
Interest expense   0.07.50.31.4  0.0
Other income (expense), net   [+]0.00.3-1.2-0.7-0.6   
Pre-tax income  -10.0-9.9-13.6-6.8-5.10.00.00.0
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -10.0-9.9-13.6-6.8-5.10.0-0.10.0
            Net margin  -5842.0%-5584.3%-700.4%    -4688.7%
   
Basic EPS   [+]($0.63)($0.93)($2.52)($0.57)($0.77)($0.01)($0.01)($0.01)
Diluted EPS   [+]($0.63)($0.93)($2.52)($0.57)($0.77)($0.01)($0.01)($0.01)
   
Shares outstanding (basic)   [+]16.010.75.411.96.65.15.15.1
Shares outstanding (diluted)   [+]16.010.75.411.96.65.15.15.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy